HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2007318164 (hide)

Owner Merck & Co., Inc.

Inventors Rudd, Michael T.; McCauley, John A.; Liverton, Nigel J.; Vacca, Joseph P.

Agent Spruson & Ferguson

Pub. Number AU-A-2007318164

PCT Pub. Number WO2008/057208

Priority 60/854,794 27.10.06 US

Filing date 23 October 2007

Wipo publication date 15 May 2008

International Classifications

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/057208 Priority application(s): WO2008/057208

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318165-HCV NS3 protease inhibitors

2007318160-Solid composition for treating water